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IN OLDER ADULTS, BIOPROSTHETIC VALVES RARELY FAIL WITHIN 5 YEARS OF THE INDEX SURGERY. Such
failures pose a challenge to patients, clinicians, and surgeons. Although clinicians are generally aware of valve
dysfunction related to overt endocarditis, patient–prosthesis mismatch, and technical error, less-recognized
causes of early bioprosthetic valve failure include valve thrombosis (Figures 1 and 2, Online Videos 1 and 2),
excessive pannus formation (Figures 3 and 4, Online Videos 3, 4, 5, and 6), and accelerated structural valve
deterioration (Figures 5 and 6, Online Videos 7, 8, 9, and 10). Given their rarity, these failure mechanisms haveFIGURE 1 Thrombi on the Nonﬂow Surface
of a Bioprosthesis Leading to Stenosis
One year after aortic valve replacement with a 25-
mm Medtronic Mosaic valve (Medtronic, Minneap-
olis, Minnesota), severe aortic stenosis recurred in a
78-year-old patient (A and B) (Online Video 1).
Thrombi suspected on transesophageal echocardi-
ography are conﬁrmed on the nonﬂow surface of
the valve (yellow arrows). A 67-year-old man
presented similarly with recurrent severe aortic
stenosis 1 year after aortic valve replacement with a
25-mm Biocor bioprosthesis (St. Jude Medical, St.
Paul, Minnesota) (C and D). Thrombi are seen on the
nonﬂow surface of the valve (C, blue arrows), and
Movat stain reveals thrombus in red and leaﬂet in
yellow-green (D). Lines of Zahn represent layering
of thrombus over time that stiffens the leaﬂet and
renders it immobile. Even though results of blood
cultures had been negative, culture of the valve
grew Propionibacterium acnes, emphasizing the
importance of a comprehensive assessment for
infection because thrombus and infective
endocarditis may both be present.
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FIGURE 2 A Large Thrombus Causing Bioprosthetic Valve Stenosis
Three years after receiving a 21-mm Carpentier-Edwards valve (Edwards Lifesciences, Irvine, California), a 51-year-old woman returned with
severe aortic stenosis and a large thrombus (green arrows, A and B) (Online Video 2). The microbiologic assessment was unremarkable, and she
received a 24-mm homograft. With aortic valve thrombosis, the threshold for root replacement may be lower because aortic homografts may
have decreased thrombogenicity.
FIGURE 3 Thrombus and Subvalvular Pannus Resulting in Bioprosthetic Valve Stenosis
One year after aortic valve replacement with a 21-mm, 3-F stentless valve (Medtronic), a 58-year-old woman returned with severe aortic
stenosis. A focal thrombus (yellow arrow, A and B) (Online Video 3) was observed, as well as extensive subvalvular pannus (pink arrowhead,
C). Movat stain of the valve (D) revealed the ﬁbrosa layer of the bovine pericardium as dark yellow-orange, rich in ﬁbrous tissue. Small thrombi
may serve as a nidus for exuberant pannus formation. Both the thrombus and subvalvular pannus contribute to immobilization of the leaﬂet
and valvular stenosis.
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FIGURE 4 Pannus Restricting Leaﬂets to
Cause Bioprosthetic Regurgitation
One year after mitral valve replacement with a
29-mm Carpentier-Edwards bioprosthesis
(Edwards Lifesciences), a 70-year-old woman
developed severe mitral regurgitation with a
restricted leaﬂet (A and B) (Online Videos 4
and 5). Focal pannus formation led to restric-
tion and infolding of the leaﬂet (yellow
arrow, B). A 46-year-old woman with repaired
tetralogy of Fallot presented 2 years after
receiving a 27-mm Carpentier-Edwards bio-
prosthesis for severe pulmonic regurgitation
(C and D) (Online Video 6). Her dyspnea had
returned, and she had recurrent severe
pulmonic regurgitation. The bioprosthesis
demonstrated extensive pannus formation
restricting all leaﬂets.
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pictorial essay, we highlight these lesser-known causes of early bioprosthetic valve failure. By recognizing
simple echocardiographic ﬁndings within a clinical context, the correct diagnosis for these infrequent pre-
sentations can be ascertained (Figure 7).FIGURE 5 Calciﬁcation Causing a Leaﬂet Tear
and Severe Bioprosthetic Regurgitation and
Extrinsic Calciﬁcation Causing Bioprosthetic
Stenosis
A 62-year-old woman presented with decom-
pensated heart failure and severe mitral
regurgitation 3 years after mitral valve
replacement with a 27-mm Medtronic Mosaic
porcine valve (A and B) (Online Video 7). At
repeat surgery, the valve was calciﬁed with a
tear in 1 leaﬂet (yellow arrow, B). A 70-year-
old woman presented in decompensated heart
failure 3 years after aortic valve replacement
with a 19-mm Mitroﬂow (Sorin Group, Milan,
Italy). An echocardiogram showed severe aortic
stenosis and moderate aortic regurgitation.
Surgery conﬁrmed abnormalities on echocar-
diogram as extensive calciﬁcation (C and D,
blue arrows) (Online Video 8). She subse-
quently received a 23-mm Trifecta bio-
prosthesis (St. Jude Medical). Concomitant
patient–prosthesis mismatch may have
contributed to the accelerated calciﬁcation.
FIGURE 6 Primary Perforation and
Endocarditis Leading to Bioprosthetic
Regurgitation
One year after receiving a 25-mm Biocor
bioprosthesis, a 73-year-old woman returned
with dyspnea on exertion and signiﬁcant aortic
regurgitation despite a post-operative
echocardiogram with no valvular dysfunction.
A follow-up echocardiogram demonstrated
valvular aortic regurgitation, and the valve had
a round perforation in 1 leaﬂet (A and B, yellow
arrow) (Online Video 9). There was no evidence
of infection or calciﬁcation. In contrast, a
76-year-old man returned with heart failure
and severe aortic regurgitation 1 year after
aortic valve replacement with a 21-mm
Carpentier-Edwards bioprosthesis. Upon
re-operation, a large tear was seen in 1 leaﬂet,
and a perforation was present in another
(C and D) (Online Video 10). Bacterial poly-
merase chain reaction assay of the explanted
valve was positive for Tropheryma whipplei.
This ﬁnding again underscores the importance
of an exhaustive search for endocarditis lest an
infected valve is mistakenly labeled as failure
due to a primary tear.
FIGURE 7 Simpliﬁed Approach to Rare Causes
of Early Bioprosthetic Valve Failure
*Risk factors include younger age, enhanced
immune response, hyperparathyroidism, dia-
betes mellitus, and mitral (as opposed to aortic)
position. †Risk factors include a history of
thromboembolic events, a sewing ring that is
not yet fully endothelialized, and a lack of
anticoagulation.
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